Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients

Different monocytic subsets are important in inflammation and tissue remodelling, but although heart failure (HF) is associated with local and systemic inflammation, their roles in HF are yet unknown. We recruited 59 chronic systolic HF patients (aged years, 45 males and 14 females) and 29 age-matc...

Full description

Saved in:
Bibliographic Details
Main Authors: Offer Amir, Ilia Spivak, Idit Lavi, Michal Amit Rahat
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/616384
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849692444969402368
author Offer Amir
Ilia Spivak
Idit Lavi
Michal Amit Rahat
author_facet Offer Amir
Ilia Spivak
Idit Lavi
Michal Amit Rahat
author_sort Offer Amir
collection DOAJ
description Different monocytic subsets are important in inflammation and tissue remodelling, but although heart failure (HF) is associated with local and systemic inflammation, their roles in HF are yet unknown. We recruited 59 chronic systolic HF patients (aged years, 45 males and 14 females) and 29 age-matched controls with no pervious heart disease. Compared to the controls, we found no change in the distribution of the CD14+CD16+ monocytic subset, whereas the classical CD14++CD16− subset was decreased by 11% (), and the nonclassical CD14dimCD16+ subset was expanded by 4% () in HF patients and was inversely associated with severe HF (), as assessed by increased end-diastolic dimension (EDD). Compared to the control group, serum TNF, IL-1, IL-10, and IL-13 levels were significantly elevated in the HF patients. Specifically, IL-13 levels were positively correlated to the CD1CD14dimCD16+ monocytic subset (, ), and intracellular staining of IL-13 demonstrated that some of these monocytes produce the cytokine in HF patients, but not in the controls. We suggest that the inverse association between EDD values and the expansion of CD1CD16+ monocytes that can produce IL-13 could be explained as a measure to counterbalance adverse remodelling, which is a central process in HF.
format Article
id doaj-art-ee0e916cc0c842d6bae0d3bb2e17c5e1
institution DOAJ
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-ee0e916cc0c842d6bae0d3bb2e17c5e12025-08-20T03:20:43ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/616384616384Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure PatientsOffer Amir0Ilia Spivak1Idit Lavi2Michal Amit Rahat3Heart Failure Center, Division of Cardiology, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, IsraelHeart Failure Center, Division of Cardiology, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, IsraelDepartment of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, IsraelImmunology Research Unit, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, IsraelDifferent monocytic subsets are important in inflammation and tissue remodelling, but although heart failure (HF) is associated with local and systemic inflammation, their roles in HF are yet unknown. We recruited 59 chronic systolic HF patients (aged years, 45 males and 14 females) and 29 age-matched controls with no pervious heart disease. Compared to the controls, we found no change in the distribution of the CD14+CD16+ monocytic subset, whereas the classical CD14++CD16− subset was decreased by 11% (), and the nonclassical CD14dimCD16+ subset was expanded by 4% () in HF patients and was inversely associated with severe HF (), as assessed by increased end-diastolic dimension (EDD). Compared to the control group, serum TNF, IL-1, IL-10, and IL-13 levels were significantly elevated in the HF patients. Specifically, IL-13 levels were positively correlated to the CD1CD14dimCD16+ monocytic subset (, ), and intracellular staining of IL-13 demonstrated that some of these monocytes produce the cytokine in HF patients, but not in the controls. We suggest that the inverse association between EDD values and the expansion of CD1CD16+ monocytes that can produce IL-13 could be explained as a measure to counterbalance adverse remodelling, which is a central process in HF.http://dx.doi.org/10.1155/2012/616384
spellingShingle Offer Amir
Ilia Spivak
Idit Lavi
Michal Amit Rahat
Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
Mediators of Inflammation
title Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
title_full Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
title_fullStr Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
title_full_unstemmed Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
title_short Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
title_sort changes in the monocytic subsets cd14dimcd16 and cd14 cd16 in chronic systolic heart failure patients
url http://dx.doi.org/10.1155/2012/616384
work_keys_str_mv AT offeramir changesinthemonocyticsubsetscd14dimcd16andcd14cd16inchronicsystolicheartfailurepatients
AT iliaspivak changesinthemonocyticsubsetscd14dimcd16andcd14cd16inchronicsystolicheartfailurepatients
AT iditlavi changesinthemonocyticsubsetscd14dimcd16andcd14cd16inchronicsystolicheartfailurepatients
AT michalamitrahat changesinthemonocyticsubsetscd14dimcd16andcd14cd16inchronicsystolicheartfailurepatients